Home > Boards > US OTC > Biotechs > Cytodyn Inc. (CYDY)

Big Pharma has a whole group dedicated to

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Beachbum3232 Member Profile
 
Followed By 3
Posts 75
Boards Moderated 0
Alias Born 02/20/19
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 6/15/2021 5:01:59 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 6/8/2021 4:32:22 PM
CEO's Presenting at Emerging Growth Conference Virtually Tomorrow InvestorsHub NewsWire - 6/8/2021 7:00:00 AM
CytoDyn's partner to submit request to conduct Phase 3 leronlimab studies in Brazil Seeking Alpha - 5/27/2021 6:33:58 AM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 5/24/2021 5:16:01 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/20/2021 5:18:50 PM
CytoDyn promotes Antonio Migliarese to CFO role Seeking Alpha - 5/20/2021 5:14:56 PM
IQST Signals BUY InvestorsHub NewsWire - 5/20/2021 9:43:19 AM
CytoDyn to submit CD12 trial data to regulatory agencies in multiple countries Seeking Alpha - 5/18/2021 7:45:54 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/17/2021 5:02:38 PM
CytoDyn plunges as FDA rebukes its clinical trials for COVID-19 therapy Seeking Alpha - 5/17/2021 3:51:07 PM
CytoDyn inks leronlimab distribution deal in India for COVID-19 Seeking Alpha - 5/13/2021 9:04:20 AM
CEO Presenting at Emerging Growth Conference Virtually This Week InvestorsHub NewsWire - 5/10/2021 7:00:00 AM
CytoDyn to conduct two COVID-19 trials in Brazil Seeking Alpha - 5/5/2021 6:25:40 AM
CytoDyn provides updates on leronlimab HIV extension arm; to hold webcast on May 5 on multiple initiatives Seeking Alpha - 5/3/2021 9:46:59 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/29/2021 4:32:06 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/21/2021 6:28:13 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/21/2021 4:31:54 PM
CytoDyn initiates rolling submission of leronlimab in COVID-19 to Canada regulator Seeking Alpha - 4/19/2021 6:54:58 AM
CytoDyn executes supply and distribution agreement with Chiral Pharma Seeking Alpha - 4/15/2021 9:34:25 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/12/2021 4:31:04 PM
CytoDyn completes enrollment in COVID-19 long-hauler trial Seeking Alpha - 4/9/2021 6:59:31 AM
CytoDyn updates on leronlimab-treated COVID-19 patient Seeking Alpha - 4/5/2021 11:51:19 AM
CytoDyn to provide full update on its activities on April 6 Seeking Alpha - 4/1/2021 6:19:48 AM
CytoDyn files new protocol with FDA for 4 doses of leronlimab for critical COVID-19 Seeking Alpha - 4/1/2021 6:13:14 AM
Beachbum3232   Thursday, 08/27/20 11:51:43 AM
Re: Black-Ops post# 111671
Post # of 170717 
Big Pharma has a whole group dedicated to publication planning. Usually for scientific data to get published in legit peer reviewed journals, but also have connections with all publications. In addition, you are dealing with the ad agencies that support the brands of these companies and usually are the ones organizing the ad spend and where it goes. Between these two groups, you can bet, BP has influence on what gets published by who, and when.


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences